Daxor corporation ceo and president michael feldschuh provides corporate update in letter to shareholders

Oak ridge, tn, sept. 01, 2021 (globe newswire) -- daxor corporation (nyse: dxr), the global leader in blood volume measurement technology, announces today it issued a corporate update in a letter to shareholders filed in its certified shareholder report on form n-csr on august 30, 2021, from ceo & president, michael feldschuh:
DXR Ratings Summary
DXR Quant Ranking